|
Volumn 57, Issue 1-2, 2003, Pages 67-71
|
Impurity profiling of non-nucleoside reverse transcriptase inhibitors by HPLC using a porous graphitic carbon stationary phase
|
Author keywords
Column liquid chromatography; Impurity profiling; Non nucleoside reverse transcriptase inhibitor; Porous graphitic carbon
|
Indexed keywords
4 (2 CYCLOPROPYLVINYL) 5,6 DIFLUORO 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
4 CYCLOPROPYLETHYNYL 5,6 DIFLUORO 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
6 CHLORO 4 (2 CYCLOPROPYLVINYL) 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
6 CHLORO 4 CYCLOPROPYLETHYNYL 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
CARBON;
EFAVIRENZ;
GRAPHITE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SILICA GEL;
TA 278;
TA 279;
UNCLASSIFIED DRUG;
ARTICLE;
COLUMN CHROMATOGRAPHY;
DRUG DEGRADATION;
DRUG DETERMINATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
POROSITY;
PRIORITY JOURNAL;
SEPARATION TECHNIQUE;
|
EID: 0037253241
PISSN: 00095893
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02497479 Document Type: Article |
Times cited : (9)
|
References (12)
|